Remdesivir
M.A.R.M.C.D./2020/2637
Phase 3 small_molecule active
Quick answer
Remdesivir for Covid19 is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Covid19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active